The Report Guru

According to the new market research report " Liquid Biopsy Market "  worth USD 2,047.9 Million by 2022, at a CAGR of 23.4%. The key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D. On the basis of product, the liquid biopsy market is broadly segmented into assays kits, instruments, and services. In 2017, the assay kits segment is expected to account for the largest share of this market. The increase in basic research and commercial applications of liquid biopsy, increase in demand for liquid biopsy tests, and the need for reliable and specific assays are expected to drive the market growth. Based on circulating biomarkers the market is categorized into circ

The blood flow measurement devices market is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 2021). Blood flow measurement devices are used to measure the volume rate of blood flow, which helps physicians to maintain equilibrium between blood supply and demand of tissue oxygen of patients. The measurement of blood flow helps in identifying blockages in the blood vessels and testing artificial blood vessels during organ transplantation, among others. These devices are imperative for diagnosing various clinical vascular conditions such as arterial occlusion, peripheral vascular diseases including diabetes, micro- and macro-vascular complications. The devices also find applications in skin testing, cerebral blood flow measurement, and burn assessment. The major market players in the blood flow measurement devices market include Medistim ASA (Norway), Transonic Systems, Inc. (U.S.),

According to the new market research report “ Veterinary Dental Market by Product (Work Station, X-Ray, Laser, Ultrasonic Scaler, Micromotor, Electrosurgical Unit, Handpieces, Forceps, Curettes, Retractors, Probe, Sclers), Animal, End User, and Region – Global Forecast to 2023″, published by MarketsandMarkets™, the Veterinary Dental Equipment Market is projected to reach USD 490 million by 2023 from USD 329 million in 2018, at a CAGR of 8.3% during the forecast period. Growth in the global companion animal population, the rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and income levels in developed economies during the forecast period are the primary drivers for the Veterinary Dental Equipment Market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837 “The dental equipment segment to account for the largest market share in 2018” On the basis of product, t

According to research report the “ Clinical Alarm Management Systems Market  by Component (Solutions, Services), Product (Nurse Call Systems, Physiological Monitors, EMR Integration Systems), End User (Hospitals, Long-term Care Centers, Ambulatory Care Centers)) – Global Forecasts to 2023″, The global clinical alarm management systems market is expected to reach USD 1,724 million by 2023 from an estimated USD 457 million in 2018, at a CAGR of 30.4% during the forecast period (2018-2023). The key factors driving the growth of this market include increasing alarm fatigue, high prevalence of chronic diseases, growth in the geriatric population, need for cost-containment in healthcare delivery, and rising prominence and usage of big data and mHealth tools. The solutions segment is expected to account for the largest share of the market in 2018 On the basis of component, the global clinical alarm management systems  market is segmented into two broad categories solutions and services

The global  contrast media injectors market  is expected to reach USD 636.1 million by 2021. Factors such as increasing number of approvals for contrast agents, increasing number of public and private diagnostic centers, technological advancements in the contrast media injector arena and the increased focus of market players in the injector technology provide high growth opportunities for players in the global contrast media injectors market. Download Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959 Interventional cardiology segment to grow at the highest CAGR during the forecast period On the basis of application, the global contrast media injectors market is segmented into interventional radiology, and interventional cardiology applications. The radiology segment is expected to account for the largest share of the global contrast media injectors market whereas the interventional cardiology segment is expected to grow at the highest CAGR. The growt

The global sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. The growth of this market is mainly driven by the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries. Agreements, collaborations, partnerships, and expansions are some of the major growth strategies followed by key players between 2015 and 2018. Key players in the sinus dilation devices market include Entellus Medical Inc. (Subsidiary of Stryker) (US), Acclarent Inc. (Subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt Ltd. (India), SinuSys Corporation (US), InAccel (India),

The global contrast media injectors market is expected to reach USD 636.1 million by 2021. Factors such as increasing number of approvals for contrast agents, increasing number of public and private diagnostic centers, technological advancements in the contrast media injector arena and the increased focus of market players in the injector technology provide high growth opportunities for players in the global contrast media injectors market. Interventional cardiology segment to grow at the highest CAGR during the forecast period On the basis of application, the global contrast media injectors market is segmented into interventional radiology, and interventional cardiology applications. The radiology segment is expected to account for the largest share of the global contrast media injectors market whereas the interventional cardiology segment is expected to grow at the highest CAGR. The growth of the market can be attributed to the high global CVD burden. According to

The coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021. The market is mainly driven by factors such as technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. A coronary stent is a small, expandable tube-shaped device placed in the coronary arteries that supply blood to the heart. Coronary stents are used in percutaneous coronary intervention (PCI) procedures to treat patients with coronary artery disease (CAD). They are used for a wide range of indications in CAD, including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions. Hospitals This segment includes both government and private hospitals that provide treatment to the patients with CAD. The market for this segment is mainly d

The global wearable medical device market , in terms of value, is projected to reach USD 12.14 billion by 2021 from USD 5.31 billion in 2016, at a CAGR of 18.0% during the forecast period. The wearable medical services market is segmented based on type, distribution channel, end use, application, and regions.  Increasing use of mobile technology is one of the major factors driving the growth of the wearable medical devices market. With the development of devices such as smartphones connected with various medical apps, wearable wrist band monitors, and cuffless blood pressure monitors, the monitoring of health conditions has become more efficient and effective. Moreover, these devices enable sharing of a patient’s medical records with doctors over a period of time, which helps in the proper diagnosis and treatment of diseases. The wearable medical devices market is expected to witness significant growth in the coming years, due to the increasing adoption of these devices in va

In the light of the escalating healthcare costs, currently, the global healthcare industry is increasingly looking forward to reduce the administrative and clinical expenditure by implementing various healthcare IT tools in their organizations. With the growing demand for simplified data-sharing among various stakeholders in the healthcare industry, majority of the software vendors are focusing on incorporating greater degree of interoperability in their product portfolio. This is one of the key factors driving innovation in the global accountable care solution market . Healthcare provider solutions (such as EHR/EMR, healthcare analytics, RCM, PHM, HIE and CDSS) and payer solutions (such as claims management solutions, payment management solutions) are at the focus of such innovations from vendors in the accountable care solutions market. Although, the global Accountable Care Solution Market is highly fragmented in nature with the presence of a number of small and medium-sized ve

The prominent players operating in the global veterinary reference laboratory market are IDEXX Laboratories, Inc. (US), VCA, Inc. (US), GD Animal Health (Netherlands), National Veterinary Services Laboratory (US), Animal and Plant Health Agency (DEFRA APHA Scientific) (UK), Animal Health Diagnostic Center (Cornell University) (US), Greencross Limited (Australia), Gribbles Veterinary Pathology (Australia), Phoenix Central Laboratory for Veterinarians, Inc. (US), Zoetis, Inc. (US), Neogen Corporation (US), ProtaTek Internationals Inc. (US), Wisconsin Veterinary Diagnostic Laboratory (US), and Washington State University Veterinary Clinical Pathology Laboratory (US). IDEXX Laboratories, Inc. (US) s engaged in the development, manufacture, marketing, and distribution of diagnostic products and services for companion animals, livestock, and poultry. In addition to diagnostics products, the company offers reference laboratory and consulting services to veterinarians, livest

The industry is consolidated in nature with the presence of many local, regional, and global players. Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), and Unilever plc (U.K.) were the major players in this market. The companies are mainly focusing on product launches, agreements, and expansions to strengthen their product offerings and establish a strong geographical foothold. According to recent research report the global oral care market is projected to reach USD 53.97 billion by 2022 from USD 43.31 billion in 2017, at a CAGR of 4.5%. Colgate-Palmolive Company (U.S.) dominated the global oral care market in 2016. The company significantly focuses on product innovation, product enhancement, and product launches; it invested USD 289 million for R&D activities in 2016. The company launched two new products, Colgate Optic White Toothbrush + Whitening Pen (the toothbrush with a built-in whitening pen) and Pain Out (a tooth pain relief product) in 2014

The global Genome Engineering Market is projected to be valued at USD 3.19 Billion in 2017 and is expected to grow at a CAGR of 14.5% to reach to USD 6.28 Billion by 2022. Thermo Fisher Scientific (US) is the leading player in the global genome editing market. The company operates in over 50 countries across North America, Europe, Asia, and Latin America. The company’s business segments include Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Services. To maintain its position and increase its customer base in the Genome Engineering Market, the company mainly focuses on expanding its market presence by adopting growth strategies, such as acquisitions, partnerships, and collaborations. For instance, in July 2016, Thermo Fisher partnered with healthBioMed (HBM) (China) to support HBM in the development of molecular diagnostics kits. Through this partnership, HBM aimed to develop pharmacogenomics kits and support the precision med

According to research report " Asia-Pacific Animal Health Market is expected to grow at a CAGR of 5.7% during the forecast period to reach USD 20.25 Billion by 2021.The report analyzes and studies the major market drivers, restraints, challenges, and opportunities in China, Japan, India, and the Rest of Asia-Pacific Browse 116 market data tables and 35 figures spread through 199 pages and in-depth TOC on “Asia-Pacific Animal Health Market by Product (Parasiticides (Endoparasiticides, Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive (Vitamin, Amino Acids, Antioxidant), Growth Promoter), Animal (Livestock, Companion) - Forecast to 2021" The APAC animal health market has witnessed significant growth during the last decade and Growth in this market can majorly be attributed to factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of

The global veterinary reference laboratory market is projected to reach USD 2.8 billion by 2021 from USD 1.7 billion in 2016, at a CAGR of 9.8%. The global veterinary reference laboratories market is dominated by IDEXX Laboratories, Inc. (U.S.) and VCA, Inc. (U.S.) which together accounted for ~60-65% of the global market in 2015. The leading position of IDEXX Laboratories, Inc. (U.S.) in this market is mainly attributed to its strong diagnostic service portfolio and strong distribution and services network across the globe. The company operates in more than 175 countries across North America, Europe, Asia-Pacific, and the Rest of the World. The company has a diversified revenue system which helps it to sustain its leading position in the market. IDEXX Laboratories primarily focuses on strengthening its veterinary diagnostic testing services portfolio and aims to maintain customer satisfaction by providing accurate and timely responses and resolutions to customer needs. The comp

The stable isotope-labeled compounds market is emerging and fragmented in nature with various regional and international players. In 2016, Cambridge Isotope Laboratories, Inc. (U.S.) and Merck KGaA (Germany) dominated the stable isotope-labeled compounds market. According to the recent research report the global stable isotope-labeled compounds market is projected to reach USD 294.2 million by 2022 from USD 254.6 million in 2017, at a CAGR of 2.9% during the forecast period. Cambridge Isotope Laboratories, Inc. specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (non-radioactive) isotopes of carbon, hydrogen, nitrogen, and oxygen. These products find application in structural biology, proteomics, genomics, molecular biology, metabolic research, clinical and diagnostic research, and ultra-trace environmental analysis. To maintain its leading position and increase its customer base in the stable isotope-labeled compounds market ,

Market growth factors The growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of this thrombectomy devices market. What experts says about the growth of this market? The global Thrombectomy devices market over the forecast period of 2017 to 2022. The market is expected to reach USD 1.45 Billion by 2022 growing at a CAGR of 6.7%. Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022 Download Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222966801    On the basis of type, the global thrombectomy devices market is segmented into aspirati

According to research report the refurbished medical equipment market is expected to reach USD 11.91 Billion by 2021 from USD 6.55 Billion in 2016, at a CAGR of 12.7% during the forecast period. Increasing privatization in the healthcare sector, poor reimbursement scenario for various medical treatments, large patient population base, and presence of a large number of hospitals/clinics with budget constraints in developing countries are the major factors driving the growth of this market. Growing initiatives undertaken by leading market players (such as GE Healthcare, Philips Healthcare, and Siemens Healthineers) to establish refurbishment facilities in both mature and developing markets are further adding to the growth prospects of Refurbished Medical Equipment market. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=770 The global refurbished medical equipment market was dominated by GE Healthcare (U.S.), Koninklijke Philips N.V. (Net

According to research report " Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) - Forecast to 2021" , Report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the urinalysis market along with the estimates and forecasts of the revenue and market share analysis . The global Urinalysis market is expected to reach USD 1.91 Billion by 2021 from USD 1.32 Billion in 2016 at a CAGR of 7.6% from 2016 to 2021. The major factors driving the growth of this market are rising prevalence of kidney diseases and urinary tract infections, implementation of PPACA, technological advancements, increasing adoption rate of point-of-care urinalysis devices, increasing healthcare expenditure and increasing geriatric popula

According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period. The major driving factors in the pacemakers market are increasing prevalence of cardiovascular diseases and technological advancements in devices. The study involved 4 major activities in estimating the current market size for pacemaker. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814 The implantable pacem

A number of key players are competing against each other in order to expand their existing customer base. In 2015, the contrast injector market was dominated by Bracco Imaging S.p.A (Italy), Bayer HealthCare (Germany), and Guerbet Group (France). Other players in this market include GE Healthcare (U.S.), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), AngioDynamics (U.S.) Sino Medical- Device Technology Co., Ltd. (China), Apollo RT Co., Ltd. (China), VIVID IMAGING (China), and Nemoto Kyorindo Co., Ltd. (Japan). Bracco Imaging S.p.A is dominating the contrast injector market in 2016. The company is engaged in the discovery, development, manufacturing, and commercialization of imaging solutions for diagnostic imaging procedures to amplify the anatomic and functional visualization of internal body organs and areas. It also provides advanced administration systems for contrast imaging products. In 2011, the company acquired Swiss Medical Care (SMC) (Switzerlan

The global clinical alarm management market is expected to reach USD 1,724 million by 2023 from an estimated USD 457 million in 2018, at a CAGR of 30.4%. The clinical alarm management market is rapidly emerging with many regional as well as international companies. In 2017, Koninklijke Philips (Netherlands) and Vocera Communications (US), held a share of approximately 70.0% of the clinical alarm management market. The major clinical alarm management vendors include Koninklijke Philips (Netherlands), Vocera Communications (US), Ascom Holdings (Switzerland), Spok, Inc. (US), Bernoulli Enterprise (US), Connexall (Canada), Mobile Heartbeat (US), GE Healthcare (US), Capsule Technologie (US), and Masimo Corporation (US).  These players have adopted various growth strategies, such as product launches and enhancements; acquisitions; expansions; and agreements, partnerships, mergers, and collaborations. Product launches and partnerships and have been the most dominating strategy adopted b